Total Payments
$17,428
2024 Payments
$10,144
Companies
7
Transactions
33
Medicare Patients
732
Medicare Billing
$125,232
Payment Breakdown by Category
Travel$11,197 (64.3%)
Consulting$2,162 (12.4%)
Food & Beverage$1,654 (9.5%)
Other$1,565 (9.0%)
Research$849.63 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $11,197 | 12 | 64.3% |
| Consulting Fee | $2,162 | 2 | 12.4% |
| Food and Beverage | $1,654 | 15 | 9.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,565 | 2 | 9.0% |
| Unspecified | $849.63 | 2 | 4.9% |
Payments by Type
General
$16,578
31 transactions
Research
$849.63
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $7,286 | 8 | $0 (2024) |
| F. Hoffmann-La Roche AG | $5,456 | 8 | $0 (2020) |
| Roche Products Limited | $3,043 | 5 | $0 (2024) |
| Sage Therapeutics, Inc. | $1,206 | 9 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $241.67 | 1 | $0 (2020) |
| Genentech, Inc. | $104.33 | 1 | $0 (2018) |
| Genentech USA, Inc. | $90.92 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,144 | 12 | Alnylam Pharmaceuticals Inc. ($7,286) |
| 2023 | $1,391 | 10 | Sage Therapeutics, Inc. ($1,206) |
| 2020 | $1,091 | 3 | F. Hoffmann-La Roche AG ($849.63) |
| 2019 | $3,575 | 4 | F. Hoffmann-La Roche AG ($3,485) |
| 2018 | $1,226 | 4 | F. Hoffmann-La Roche AG ($1,121) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $194.53 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $176.56 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $176.56 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $66.21 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $33.11 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $16.55 | General |
| 09/10/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $16.55 | General |
| 07/18/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $6,606.02 | General |
| 05/22/2024 | Roche Products Limited | — | Travel and Lodging | Cash or cash equivalent | $1,368.02 | General |
| 05/22/2024 | Roche Products Limited | — | Travel and Lodging | Cash or cash equivalent | $673.14 | General |
| 05/22/2024 | Roche Products Limited | — | Food and Beverage | In-kind items and services | $504.10 | General |
| 05/22/2024 | Roche Products Limited | — | Travel and Lodging | Cash or cash equivalent | $312.66 | General |
| 11/03/2023 | Roche Products Limited | — | Food and Beverage | In-kind items and services | $185.42 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $268.85 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 08/17/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 08/16/2023 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $444.03 | General |
| 08/16/2023 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $200.62 | General |
| 08/16/2023 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 12/31/2020 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | — | In-kind items and services | $575.90 | Research |
| Study: OLE Open Label Extension of Phase I IIa • Category: None | ||||||
| 06/30/2020 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | — | In-kind items and services | $273.73 | Research |
| Study: Intrathecal antisense oligonucleotide delivery in Huntington's disease Experience from tominersen programme and best practice considerations • Category: None | ||||||
| 01/27/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $241.67 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OLE Open Label Extension of Phase I IIa | F. Hoffmann-La Roche AG | $575.90 | 1 |
| Intrathecal antisense oligonucleotide delivery in Huntington's disease Experience from tominersen programme and best practice considerations | F. Hoffmann-La Roche AG | $273.73 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 170 | 298 | $92,234 | $29,521 |
| 2022 | 3 | 183 | 358 | $91,612 | $32,405 |
| 2021 | 3 | 199 | 355 | $96,199 | $35,436 |
| 2020 | 3 | 180 | 235 | $83,025 | $27,870 |
Total Patients
732
Total Services
1,246
Medicare Billing
$125,232
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 168 | $68,508 | $22,994 | 33.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $12,384 | $3,665 | 29.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 51 | 106 | $11,342 | $2,863 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 168 | $60,648 | $23,713 | 39.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 76 | 164 | $17,548 | $4,453 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $13,416 | $4,240 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 93 | 168 | $60,648 | $24,311 | 40.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 38 | 38 | $19,608 | $6,825 | 34.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 68 | 149 | $15,943 | $4,300 | 27.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 75 | 110 | $39,710 | $12,862 | 32.4% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 75 | 95 | $27,835 | $10,323 | 37.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 30 | 30 | $15,480 | $4,685 | 30.3% |
About Dr. Jee Bang, M.D
Dr. Jee Bang, M.D is a Internal Medicine healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225265937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jee Bang, M.D has received a total of $17,428 in payments from pharmaceutical and medical device companies, with $10,144 received in 2024. These payments were reported across 33 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($11,197).
As a Medicare-enrolled provider, Bang has provided services to 732 Medicare beneficiaries, totaling 1,246 services with total Medicare billing of $125,232. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Worcester, MA
- Active Since 06/20/2009
- Last Updated 06/20/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225265937
Products in Payments
- Non-Covered Product (Drug) $5,456
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Worcester
Jonathan Kay, Md, MD
Internal Medicine — Payments: $341,486
Internal Medicine $341,486
Leslie Harrold, M.d, M.D
Internal Medicine — Payments: $81,558
Internal Medicine $81,558
Bogdan Nedelescu, M.d, M.D
Internal Medicine — Payments: $50,128
Internal Medicine $50,128
Nikhil Shah, M.d, M.D
Internal Medicine — Payments: $39,924
Internal Medicine $39,924
Dr. Deepa Jagadeesh, M.d, M.D
Internal Medicine — Payments: $37,078
Internal Medicine $37,078
Dr. Julia Andrieni, M.d, M.D
Internal Medicine — Payments: $35,880
Internal Medicine $35,880